{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:32:16Z","timestamp":1793608336782,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08254-x","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:08:19Z","timestamp":1748365699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lactobacillus rhamnosus GG maintains gut microbiota stability and promotes intestinal adaptation via activated intestinal farnesoid X receptor signaling in short bowel syndrome"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-879X","authenticated-orcid":false,"given":"Linling","family":"Gui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2305-3369","authenticated-orcid":false,"given":"Weiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3582-3408","authenticated-orcid":false,"given":"Weibing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"8254_CR1","doi-asserted-by":"crossref","unstructured":"Carter, J. et al. Gut microbiota modulation of short bowel syndrome and the gut-brain axis. Nutrients 15, 2581 (2023).","DOI":"10.3390\/nu15112581"},{"key":"8254_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S2468-1253(19)30078-0","volume":"4","author":"T Vanuytsel","year":"2019","unstructured":"Vanuytsel, T. Disease modifying therapy in short bowel syndrome: finally coming of age?.  Lancet Gastroenterol. Hepatol. 4, 328\u2013329 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"8254_CR3","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3390\/nu15102341","volume":"15","author":"C Caporilli","year":"2023","unstructured":"Caporilli, C., Giann\u00ec, G., Grassi, F. & Esposito, S. An overview of short-bowel syndrome in pediatric patients: focus on clinical management and prevention of complications. Nutrients 15, 2341 (2023).","journal-title":"Nutrients"},{"key":"8254_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jpen.1423","volume":"43","author":"E Neelis","year":"2019","unstructured":"Neelis, E. et al. The gut microbiome in patients with intestinal failure: current evidence and implications for clinical practice. Jpen. J. Parenter. Enter. Nutr. 43, 194\u2013205 (2019).","journal-title":"Jpen. J. Parenter. Enter. Nutr."},{"key":"8254_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/0148607116658762","volume":"41","author":"HG Piper","year":"2017","unstructured":"Piper, H. G. et al. Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome. J. Parenter. Enter. Nutr. 41, 1202\u20131212 (2017).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"8254_CR6","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3748\/wjg.v29.i22.3400","volume":"29","author":"I Efremova","year":"2023","unstructured":"Efremova, I. et al. Epidemiology of small intestinal bacterial overgrowth. World J. Gastroenterol. 29, 3400\u20133421 (2023).","journal-title":"World J. Gastroenterol."},{"key":"8254_CR7","doi-asserted-by":"publisher","first-page":"1185463","DOI":"10.3389\/fmicb.2023.1185463","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Jiao, J., Yao, D., Guo, F. & Li, Y. Altered fecal microbiome and metabolome profiles in rat models of short bowel syndrome. Front. Microbiol. 14, 1185463 (2023).","journal-title":"Front. Microbiol."},{"key":"8254_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1940792","volume":"13","author":"R Th\u00e4nert","year":"2021","unstructured":"Th\u00e4nert, R. et al. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes 13, 1940792 (2021).","journal-title":"Gut Microbes"},{"key":"8254_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jhep.2014.06.025","volume":"61","author":"PM Pereira-Fantini","year":"2014","unstructured":"Pereira-Fantini, P. M. et al. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease. J. Hepatol. 61, 1115\u20131125 (2014).","journal-title":"J. Hepatol."},{"key":"8254_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jhep.2015.01.004","volume":"62","author":"A Mutanen","year":"2015","unstructured":"Mutanen, A., Lohi, J., Heikkil\u00e4, P., Jalanko, H. & Pakarinen, M. P. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure. J. Hepatol. 62, 1391\u20131397 (2015).","journal-title":"J. Hepatol."},{"key":"8254_CR11","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.3390\/nu14214660","volume":"14","author":"J Bettag","year":"2022","unstructured":"Bettag, J. et al. Novel therapeutic approaches for mitigating complications in short bowel syndrome. Nutrients 14, 4660 (2022).","journal-title":"Nutrients"},{"key":"8254_CR12","doi-asserted-by":"publisher","first-page":"2201155","DOI":"10.1080\/19490976.2023.2201155","volume":"15","author":"R Ruigrok","year":"2023","unstructured":"Ruigrok, R., Weersma, R. K. & Vich Vila, A. The emerging role of the small intestinal microbiota in human health and disease. Gut Microbes 15, 2201155 (2023).","journal-title":"Gut Microbes"},{"key":"8254_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23198-5","volume":"8","author":"HC Villmones","year":"2018","unstructured":"Villmones, H. C. et al. Species level description of the human ileal bacterial microbiota. Sci. Rep. 8, 4736 (2018).","journal-title":"Sci. Rep."},{"key":"8254_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jpeds.2009.12.008","volume":"156","author":"CR Cole","year":"2010","unstructured":"Cole, C. R. et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses.  J. Pediatr. 156, 941\u2013947.e941 (2010).","journal-title":"J. Pediatr."},{"key":"8254_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology 71, 2050\u20132066 (2020).","journal-title":"Hepatology"},{"key":"8254_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-nutr-011720-122203","volume":"40","author":"J Le Beyec","year":"2020","unstructured":"Le Beyec, J., Billiauws, L., Bado, A., Joly, F. & Le Gall, M. Short bowel syndrome: a paradigm for intestinal adaptation to nutrition?. Annu. Rev. Nutr. 40, 299\u2013321 (2020).","journal-title":"Annu. Rev. Nutr."},{"key":"8254_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcmgh.2018.01.024","volume":"6","author":"J Marchix","year":"2018","unstructured":"Marchix, J., Goddard, G. & Helmrath, M. A. Host-gut microbiota crosstalk in intestinal adaptation. Cell. Mol. Gastroenterol. Hepatol. 6, 149\u2013162 (2018).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"8254_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jpedsurg.2009.01.031","volume":"44","author":"MC Struijs","year":"2009","unstructured":"Struijs, M. C., Diamond, I. R., de Silva, N. & Wales, P. W. Establishing norms for intestinal length in children. J. Pediatr. Surg. 44, 933\u2013938 (2009).","journal-title":"J. Pediatr. Surg."},{"key":"8254_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/pathogens10081021","volume":"10","author":"IA Hajam","year":"2021","unstructured":"Hajam, I. A. et al. Anti-inflammatory properties of plasma from children with short bowel syndrome. Pathogens 10, 1021 (2021).","journal-title":"Pathogens"},{"key":"8254_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0084-7","volume":"3","author":"H Engstrand Lilja","year":"2015","unstructured":"Engstrand Lilja, H., Wefer, H., Nystr\u00f6m, N., Finkel, Y. & Engstrand, L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome 3, 18 (2015).","journal-title":"Microbiome"},{"key":"8254_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/CEG.S4343","volume":"1","author":"CM Payne","year":"2008","unstructured":"Payne, C. M., Bernstein, C., Dvorak, K. & Bernstein, H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin. Exp. Gastroenterol. 1, 19\u201347 (2008).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"8254_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0022-3476(97)80058-3","volume":"131","author":"SS Kaufman","year":"1997","unstructured":"Kaufman, S. S. et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome.  J. Pediatr. 131, 356\u2013361 (1997).","journal-title":"J. Pediatr."},{"key":"8254_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jpen.2224","volume":"46","author":"MK Hvistendahl","year":"2022","unstructured":"Hvistendahl, M. K. et al. Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: the randomized, glepaglutide phase 2 trial. J. Parenter. Enter. Nutr. 46, 923\u2013935 (2022).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"8254_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcmgh.2017.02.008","volume":"4","author":"PM Pereira-Fantini","year":"2017","unstructured":"Pereira-Fantini, P. M. et al. Farnesoid X receptor agonist treatment alters bile acid metabolism but exacerbates liver damage in a piglet model of short-bowel syndrome. Cell. Mol. Gastroenterol. Hepatol. 4, 65\u201374 (2017).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"8254_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2232143","volume":"15","author":"B Han","year":"2023","unstructured":"Han, B. et al. Gut microbiota-related bile acid metabolism-FXR\/TGR5 axis impacts the response to anti-\u03b14\u03b27-integrin therapy in humanized mice with colitis. Gut microbes 15, 2232143 (2023).","journal-title":"Gut microbes"},{"key":"8254_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-12-164","volume":"12","author":"H Ajouz","year":"2014","unstructured":"Ajouz, H., Mukherji, D. & Shamseddine, A. Secondary bile acids: an underrecognized cause of colon cancer. World J. Surg. Oncol. 12, 164 (2014).","journal-title":"World J. Surg. Oncol."},{"key":"8254_CR27","doi-asserted-by":"publisher","first-page":"2149214","DOI":"10.1080\/19490976.2022.2149214","volume":"14","author":"F Gorreja","year":"2022","unstructured":"Gorreja, F. & Walker, W. A. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies. Gut Microbes 14, 2149214 (2022).","journal-title":"Gut Microbes"},{"key":"8254_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jss.2020.01.024","volume":"251","author":"HG Piper","year":"2020","unstructured":"Piper, H. G. et al. The impact of lactobacillus probiotics on the gut microbiota in children with short bowel syndrome. J. Surg. Res 251, 112\u2013118 (2020).","journal-title":"J. Surg. Res"},{"key":"8254_CR29","doi-asserted-by":"publisher","first-page":"864397","DOI":"10.3389\/fped.2022.864397","volume":"10","author":"L Merras-Salmio","year":"2022","unstructured":"Merras-Salmio, L. & Pakarinen, M. P. Infection prevention and management in pediatric short bowel syndrome. Front. Pediatr. 10, 864397 (2022).","journal-title":"Front. Pediatr."},{"key":"8254_CR30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/jpen.1044","volume":"42","author":"J Wu","year":"2018","unstructured":"Wu, J. et al. Soluble mediators from lactobacillus rhamnosus gorbach-goldin support intestinal barrier function in rats after massive small-bowel resection. J. Parenter. Enter. Nutr. 42, 1026\u20131034 (2018).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"8254_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/nu5030679","volume":"5","author":"VS Reddy","year":"2013","unstructured":"Reddy, V. S., Patole, S. K. & Rao, S. Role of probiotics in short bowel syndrome in infants and children-a systematic review. Nutrients 5, 679\u2013699 (2013).","journal-title":"Nutrients"},{"key":"8254_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0148607104028004210","volume":"28","author":"AL Bartholome","year":"2004","unstructured":"Bartholome, A. L., Albin, D. M., Baker, D. H., Holst, J. J. & Tappenden, K. A. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. J. Parenter. Enter. Nutr. 28, 210\u2013222 (2004).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"8254_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/gutjnl-2018-316226","volume":"68","author":"TE Riehl","year":"2019","unstructured":"Riehl, T. E. et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut 68, 1003\u20131013 (2019).","journal-title":"Gut"},{"key":"8254_CR34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.02.022","volume":"164","author":"KA Fogelson","year":"2023","unstructured":"Fogelson, K. A., Dorrestein, P. C., Zarrinpar, A. & Knight, R. The gut microbial bile acid modulation and its relevance to digestive health and diseases. Gastroenterology 164, 1069\u20131085 (2023).","journal-title":"Gastroenterology"},{"key":"8254_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00518-22","volume":"10","author":"X Ye","year":"2022","unstructured":"Ye, X. et al. FXR signaling-mediated bile acid metabolism is critical for alleviation of cholesterol gallstones by lactobacillus strains. Microbiol. Spectr. 10, e0051822 (2022).","journal-title":"Microbiol. Spectr."},{"issue":"Suppl 1","key":"8254_CR36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/MCG.0000000000001170","volume":"53","author":"L Capurso","year":"2019","unstructured":"Capurso, L. Thirty years of lactobacillus rhamnosus GG: a review. J. Clin. Gastroenterol. 53 (Suppl 1), S1\u2013s41 (2019).","journal-title":"J. Clin. Gastroenterol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08254-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:08:20Z","timestamp":1748365700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8254"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08254-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"816"}}